Sun Biopharma Inc. (SNBP): Price and Financial Metrics

Sun Biopharma Inc. (SNBP)

Today's Latest Price: $3.50 USD

0.20 (6.06%)

Updated Nov 24 3:59pm

Add SNBP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SNBP Stock Price Chart Interactive Chart >

Price chart for SNBP

SNBP Price/Volume Stats

Current price $3.50 52-week high $10.00
Prev. close $3.30 52-week low $2.37
Day low $3.42 Volume 6,700
Day high $3.58 Avg. volume 27,182
50-day MA $3.08 Dividend yield N/A
200-day MA $4.04 Market Cap 33.77M

Sun Biopharma Inc. (SNBP) Company Bio

Sun BioPharma Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.

SNBP Latest News Stream

Event/Time News Detail
Loading, please wait...

SNBP Latest Social Stream

Loading social stream, please wait...

View Full SNBP Social Stream

Latest SNBP News From Around the Web

Below are the latest news stories about Sun BioPharma Inc that investors may wish to consider to help them evaluate SNBP as an investment opportunity.

Sun Biopharma prices $10.5M equity offering

Sun BioPharma (SNBP) has priced public offering of 2,545,454 common stock and the same number of warrants at $4.125/share and warrant, for gross proceeds of ~$10.5M.Each warrant entitles the holder to purchase one share of common stock at $4.54 /share. The company will kick-off trading today on Nasdaq Capital Market....

Seeking Alpha | August 28, 2020

IPO Update: Sun BioPharma Presents IPO Terms

Quick Take Sun BioPharma (SNBP) intends to raise $10 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is developing a treatment candidate for pancreatic cancer. SNBP is a thinly capitalized firm operating in a very difficult area of research,...

Donovan Jones on Seeking Alpha | August 21, 2020

Read More 'SNBP' Stories Here

SNBP Price Returns

1-mo 22.38%
3-mo -63.16%
6-mo -32.69%
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 0.00%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7556 seconds.